Quote | Super Quote
52759 HS#HSCEIRC2607A (R BULL)
RT Nominal unchange0.370 0.000 (0.000%)

10/11/2025 16:06

{I-bank focus}CCB raises BeOne Medicines (06160) to HKD234

[ET Net News Agency, 10 November 2025] CCB International raised the target price for
BeOne Medicines (06160) to HKD234 from HKD230 and maintained the "outperform" rating.
The research house said it raises adjusted earnings (Non-GAAP) for 2025F from USD556m to
USD984m, for 2026F from USD860m to USD1.0b, and for 2027F from USD2.5b to USD2.7b. (rc)

Back to Related News

Remark: Real time quote last updated: 27/11/2025 17:02
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.